ROXCELL, INC. – Trademark Portfolio

Entity Type: 03

ROXCELL, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include SUN-D, STROMEGA, G-VITAL PLUS, and NATURE'S ROYALTY. The owner is based in TUSTIN, CA.

SUITE D

14712 FRANKLIN AVE.

TUSTIN, CA 92780

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ROXCELL, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does ROXCELL, INC. have?

ROXCELL, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 1 cancelled.

What trademark classes does ROXCELL, INC. file in?

ROXCELL, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ROXCELL, INC.'s most well-known trademarks?

ROXCELL, INC.'s registered trademark portfolio includes well-known marks such as SUN-D, STROMEGA, G-VITAL PLUS, and NATURE'S ROYALTY. These are among 4 currently registered trademarks in the portfolio.

What is ROXCELL, INC.'s trademark registration success rate?

ROXCELL, INC. has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.